Key Transaction Details

  • Transaction Type: Acquisition of manufacturing facility on slump sale basis
  • Counterparty: Kaygee Laboratories Private Limited (KLPL), a related party
  • Facility Location: Plot No. 6, New Industrial Area - II, Mandideep, Dist Raisen - 462046, Madhya Pradesh
  • Assets Included: Leasehold land (22,304 sq mtr), industrial buildings (5,227 sq mtr), plant & machinery, licenses, permits, employees
  • Consideration: ₹29.98 crores (Rupees Twenty-Nine Crores Ninety Eight Lakhs Only)
  • Valuation Basis: Independent valuation report dated July 24, 2026 by S R Valuers (IBBI Registered Valuer: Regn No. IBBI/RV/04/2022/14808)

Voting Arrangements

  • Cut-off Date: August 14, 2026
  • Dispatch Date: August 18, 2026
  • E-voting Period: August 20, 2026 (9:00 AM IST) to September 18, 2026 (5:00 PM IST)
  • Service Provider: National Securities Depository Limited (NSDL)
  • Scrutinizer: Mr. Alok Khairwar (FCS No. 10031, CP 12880) or alternatively Mr. Rajkumar Gupta (ACS No. 43015, CP 18582)
  • Result Declaration: Within 2 working days from conclusion of e-voting
  • Deemed Resolution Date: September 18, 2026 if approved

Financial Impact and Rationale

  • Represents 33.22% of the company's annual turnover for FY 2025-26
  • Funding: Partly from internal accruals and partly through borrowings
  • Strategic Rationale: Achieve vertical integration in Pyridine, collidines and their derivatives; secure uninterrupted supply of chemical intermediates and APIs; enhance operational control and efficiency; eliminate outsourcing costs
  • The facility was recently inspected and approved by WHO, Geneva

Historical Relationship with Related Party

  • KLPL has been manufacturing chemical intermediates and APIs for Resonance under job work agreement
  • Previous transactions with KLPL: ₹3.72 crores (April-June 2026) and ₹16.78 crores (April 2025-March 2026)
  • KLPL Financials (FY 2024-25): Total Income ₹29.32 crores, PAT ₹9.21 crores, Net Worth ₹23.04 crores

Related Party Ownership Structure

  • Mr. Prashant Godha: Non-Executive, Promoter Director of Resonance, Director of KLPL, holds 2.08% in Makers Laboratories Limited (which holds 45.48% in Resonance)
  • Mr. Charchit Jain: Whole-time, Professional Director of Resonance, Director of KLPL
  • KLPL Shareholding: Indirectly holds 14.35% of Makers Laboratories Limited
  • Kaygee Investments Private Limited: Holds 8.77% of Resonance's equity share capital

Inspection Availability

Documents available for inspection from August 20, 2026 to September 19, 2026 via email request to investors@resonancesl.com